SOURCE: Industrial Info Resources

Industrial Info Resources

October 31, 2014 06:15 ET

Mid-Atlantic Claims $8.5 Billion Slice of $62 Billion North American Life Science Capital/MRO Investment Pie, an Industrial Info News Alert

SUGAR LAND, TX--(Marketwired - Oct 31, 2014) - Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- There are more than 1,400 active reported Pharmaceutical-Biotech capital and maintenance (MRO) projects in North America, representing a total investment value (TIV) of nearly $62 billion. According to a recent analysis of Industrial Info's Pharmaceutical-Biotech Industry database, the Mid-Atlantic region is at the top of that investment, accounting for an $8.5 billion portion of that spending divided over 176 projects.

Within this article: Details on the industry's outlook and key projects, including those from major companies such as United Therapeutics Corporation (NASDAQ:UTHR).

For details, view the entire article by subscribing to Industrial Info's Premium Industry News, or browse other breaking industrial news stories at

Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, three offices in North America and 10 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the "Contact Us" page.

Contact Information

  • Contact:
    William Ploch